Core Viewpoint - Aptiv PLC is expected to report an increase in fourth-quarter earnings and revenue compared to the previous year [1][2] Group 1: Earnings Expectations - Analysts anticipate Aptiv will report fourth-quarter earnings of $1.86 per share, up from $1.75 per share in the same period last year [1] - The consensus estimate for Aptiv's quarterly revenue is $5.11 billion, an increase from $4.91 billion reported last year [1] Group 2: Recent Performance - On October 30, Aptiv reported stronger-than-expected third-quarter earnings, exceeding Wall Street expectations [2] - Following the earnings report, shares of Aptiv fell by 3.9%, closing at $75.75 [2]

Core Insights - Parker-Hannifin Corporation reported better-than-expected second-quarter financial results and raised its FY26 guidance [1][2] Financial Performance - Adjusted EPS for the second quarter was $7.65, surpassing the analyst estimate of $7.17 [1] - Net sales reached $5.174 billion, exceeding the estimate of $5.066 billion, with a year-over-year sales increase of 9% and organic sales growth of 6.6% [1] Guidance Updates - For fiscal 2026, GAAP EPS guidance was raised to a range of $26.26 to $26.86 from a previous range of $25.53 to $26.33, compared to a $26.46 estimate [2] - Adjusted EPS guidance was increased to $30.40 to $31.00 from $29.60 to $30.40, against a $30.33 estimate [2] - Sales guidance was raised to a range of $20.942 billion to $21.339 billion from $20.644 billion to $21.239 billion, compared to a $21.106 billion estimate [3] Market Reaction - Following the earnings announcement, Parker-Hannifin shares fell by 1.6% to trade at $933.42 [3] Analyst Ratings - Stifel analyst Nathan Jones maintained a Hold rating and raised the price target from $941 to $965 [4] - Wells Fargo analyst Joseph O'Dea maintained an Overweight rating and increased the price target from $1,000 to $1,050 [4] - Barclays analyst Julian Mitchell also maintained an Overweight rating, boosting the price target from $990 to $1,020 [4]

Lam Research Corp. (NASDAQ:LRCX) posted upbeat second-quarter earnings on Wednesday.Lam Research reported quarterly earnings of $1.27 per share, which beat the Street estimate of $1.17 by 8.45%, according to Benzinga Pro. Quarterly revenue of $5.35 billion beat the analyst consensus estimate of $5.24 billion and was up from $4.38 billion from the same period last year."Lam delivered another strong quarter to cap a record year," said Tim Archer, Lam Research CEO.Lam Research is looking for third-quarter adju ...

Lam Research Corp. (NASDAQ:LRCX) posted upbeat second-quarter earnings on Wednesday.Lam Research reported quarterly earnings of $1.27 per share, which beat the Street estimate of $1.17 by 8.45%, according to Benzinga Pro. Quarterly revenue of $5.35 billion beat the analyst consensus estimate of $5.24 billion and was up from $4.38 billion from the same period last year."Lam delivered another strong quarter to cap a record year," said Tim Archer, Lam Research CEO.Lam Research is looking for third-quarter adju ...

Core Insights - Sysco Corporation reported strong second-quarter fiscal 2026 earnings, with adjusted earnings per share of 99 cents, surpassing the analyst consensus estimate of 98 cents [1] - Quarterly sales reached $20.762 billion, closely aligning with the expected $20.767 billion, reflecting a 3.0% year-over-year increase [1] Financial Performance - The company achieved its third consecutive quarter of sequentially improving local case growth, with USFS local case volume showing a positive growth of 1.2% in the quarter [2] - Sysco expects fiscal 2026 adjusted EPS growth to be at the high end of its previously provided guidance range of $4.50-$4.60, consistent with its long-term financial targets [2] Adjusted EPS Outlook - Sysco's CFO announced an increase in the full-year adjusted EPS outlook to the high end of the prior range, despite facing a headwind of approximately $100 million, or $0.16 per diluted share, from lower incentive compensation in fiscal 2025 [3] - Sysco shares closed at $83.92 following the earnings announcement [3] Analyst Ratings and Price Targets - Barclays analyst Jeffrey Bernstein maintained an Overweight rating on Sysco and raised the price target from $88 to $92 [4] - Wells Fargo analyst Edward Kelly also maintained an Overweight rating and increased the price target from $88 to $92 [4] - Piper Sandler analyst Brian Mullan maintained a Neutral rating and raised the price target from $80 to $83 [4]

Core Viewpoint - HCA Healthcare Inc. reported mixed financial results for the fourth quarter of 2025, with revenues slightly below expectations but adjusted earnings exceeding forecasts [1][2]. Financial Performance - Total revenues for HCA Healthcare in Q4 2025 were $19.513 billion, a 6.7% increase year-over-year, but below the consensus estimate of $19.67 billion [1]. - Adjusted earnings per share were $8.01, up from $6.22 a year ago, surpassing the consensus estimate of $7.43 [1]. Future Outlook - HCA Healthcare forecasts fiscal 2026 earnings per share in the range of $29.10 to $31.50, compared to the consensus estimate of $29.54 [2]. - The company anticipates 2026 sales between $76.5 billion and $80 billion, while the consensus is $79.08 billion [2]. Stock Performance - HCA Healthcare shares closed at $505.84 following the earnings announcement [3]. - Analysts have adjusted their price targets for HCA Healthcare after the earnings report [3].

Core Viewpoint - GE Vernova Inc. is expected to report significant earnings growth in the fourth quarter, with earnings per share projected to rise to $3.13 from $1.73 year-over-year, despite a slight decline in quarterly revenue expectations [1]. Group 1: Earnings and Revenue Expectations - GE Vernova is anticipated to release its fourth-quarter earnings on January 28, with expected earnings of $3.13 per share, an increase from $1.73 per share in the same quarter last year [1]. - The consensus estimate for quarterly revenue is $10.22 billion, down from $10.56 billion reported in the previous year [1]. Group 2: Recent Company Developments - On December 9, GE Vernova raised its FY28 outlook, increased its dividend, and expanded its buyback authorization, leading to a 4% increase in share price, closing at $692.70 [2]. Group 3: Analyst Ratings and Price Targets - Citigroup analyst Andrew Kaplowitz maintained a Neutral rating and raised the price target from $658 to $708 [3]. - GLJ Research analyst Austin Wang maintained a Buy rating and increased the price target from $758 to $1,087 [3]. - Baird analyst Ben Kallo downgraded the stock from Outperform to Neutral, cutting the price target from $816 to $649 [3]. - Barclays analyst Julian Mitchell maintained an Overweight rating and raised the price target from $800 to $830 [3]. - RBC Capital analyst Christopher Dendrinos maintained an Outperform rating with a price target of $761 [3].

Summary of AMD Conference Call Company Overview - The company discussed is Advanced Micro Devices (AMD) Key Points - Piper Sandler raised the target price for AMD from $280 to $300, maintaining an "Overweight" rating [1] - The firm expressed strong optimism regarding guidance for the upcoming March quarter of 2026 [1] - For the December quarter of 2025, analysts expect AMD's revenue to exceed Wall Street expectations by approximately $200 million, with potential for even higher figures [1] - There is an anticipated upward potential of at least $0.02 in earnings per share [1] - Despite seasonal impacts from client, gaming, and EPYC CPU demand, the upward momentum for the March quarter's performance may be limited but still possesses potential [1]

Core Viewpoint - First Citizens BancShares Inc reported strong fourth-quarter earnings, exceeding analyst expectations in both earnings per share and sales figures [1][2]. Financial Performance - The company posted quarterly earnings of $51.27 per share, surpassing the analyst consensus estimate of $43.91 per share [1]. - Quarterly sales reached $2.435 billion, exceeding the analyst consensus estimate of $2.289 billion [1]. Management Commentary - Chairman and CEO Frank B. Holding, Jr. highlighted solid return metrics, stable credit quality, and strong loan growth, particularly in Global Fund Banking [2]. - The company returned an additional $900 million to stockholders through share repurchases and prepaid $2.5 billion of the Purchase Money Note [2]. - The management expressed optimism about prospects for 2026 [2]. Analyst Reactions - Barclays analyst Jason Goldberg maintained an Equal-Weight rating and lowered the price target from $2,456 to $2,346 [4]. - Citigroup analyst Benjamin Gerlinger maintained a Neutral rating and cut the price target from $2,250 to $2,100 [4]. - TD Cowen analyst Steven Alexopoulos maintained a Buy rating but reduced the price target from $2,600 to $2,500 [4].

United Parcel Service, Inc. (NYSE:UPS) will release earnings results for the fourth quarter, before the opening bell on Tuesday, Jan. 27.Analysts expect the Atlanta, Georgia-based company to report quarterly earnings at $2.2 per share, down from $2.75 per share in the year-ago period. The consensus estimate for United Parcel Service's quarterly revenue is $24.01 billion, versus $25.3 billion a year earlier, according to data from Benzinga Pro.On Oct. 28, UPS reported better-than-expected third-quarter finan ...